Action MIRA MIRA PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues MIRA Pharmaceuticals, Inc.

Actions

MIRA

US60458C1045

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 31/05/2024 		Varia. 5j. Varia. 1 janv.
0,8182 USD +2,28% Graphique intraday de MIRA Pharmaceuticals, Inc. -7,55% -22,08%
29/05 Mise a jour sectorielle : Les actions du secteur de la sante chutent en fin d'apres-midi MT
29/05 Mise a jour sectorielle : Les actions du secteur de la sante reculent mercredi apres-midi MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Sector Update: Health Care Stocks Fall Late Afternoon
Sector Update: Health Care Stocks Retreat Wednesday Afternoon
Mira Pharmaceuticals Says US DEA Finds Marijuana Analog a Non-Controlled Substance
MIRA Pharmaceuticals, Inc. Announces DEA Rules Mira-55, A Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as A Controlled Substance
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, A Differentiated Oral Ketamine Analog
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Mira Pharmaceuticals, Inc. Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mira Pharmaceuticals Inc. Announces Appointment of Itzchak Angel as Chief Scientific Advisor
MIRA Pharmaceuticals, Inc. Announces Management Changes
MIRA Pharmaceuticals, Inc. Provides Updated Information Regarding the Patented, Pre-Clinical Drug Candidate Molecule Known as Mira1a
MIRA Pharmaceuticals, Inc. Announces Resignation of Christos Nicholoudis from the Board of Directors and as Part-Time General Counsel
MIRA Pharmaceuticals, Inc. Releases Breakthrough Data from Artificial Intelligence Simulations
Sector Update: Health Care Stocks Advance in Late Afternoon Trading
Top MIdday Gainers
Sector Update: Health Care Stocks Advance in Afternoon Trading
Sector Update: Health Care
Mira Pharmaceuticals Signs Licensing Deal for Ketamine Analog Ketamir-2
MIRA Pharmaceuticals, Inc. Approves Appointment of Michael Jerman to the Board
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MIRA
  4. Actualités MIRA Pharmaceuticals, Inc.
  5. Autres langues
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT